Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 16:10 ET | Source: Seneca Foods Corp.

Seneca Foods Reports Sales and Earnings for the Quarter and Nine Months Ended December 27, 2025

FAIRPORT, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the third quarter and nine months ended December 27, 2025. ...
January 28, 2026 10:00 ET | Source: The Chicago Council on Global Affairs

Survey: Americans Increasingly Divided on Key Foreign Policy Challenges

Chicago, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Deepening political polarization within the United States is eroding longstanding bipartisan public consensus on key American foreign...
January 26, 2026 11:13 ET | Source: OverDrive

Libby and Kanopy 2025 Survey Reveals a New Era of Undergraduate Learning: Students Move Beyond Traditional Text in Favor of Multimodal, Active Education

CLEVELAND, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Libby and Kanopy recently released the results of its 2025 Higher Education Survey. The findings reveal a significant shift in student expectations,...
January 25, 2026 18:30 ET | Source: Biogen Inc.

FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA...
January 21, 2026 12:06 ET | Source: HelloNation Staff Writer

How Real Estate Expert Shawna Norry of Libby, MT, Explains Northwest Montana Land for HelloNation

LIBBY, Mont., Jan. 21, 2026 (GLOBE NEWSWIRE) -- What should a buyer know before choosing a piece of northwest Montana land in Libby, Montana, Troy, Montana, or the Yaak? A HelloNation article...
January 05, 2026 20:00 ET | Source: Biogen Inc.

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

TOKYO and CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
December 19, 2025 08:45 ET | Source: MediPharm Labs Corp.

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs
December 11, 2025 10:00 ET | Source: Eclipse Energy, Inc.

Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies

Eclipse Energy today announced a collaborative partnership and capital investment with Weatherford International plc to commercialize subsurface cleantech.
December 09, 2025 13:27 ET | Source: OverDrive

Kanopy Announces Its Most-Watched Films, Documentaries, Kids Titles, TV Series, & World Cinema of 2025

CLEVELAND, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kanopy, the leading ad-free, subscription-free streaming platform available through public libraries and academic institutions, today announced its...
December 08, 2025 18:30 ET | Source: Biogen Inc.

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List

TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...